(18295396), R. A., (3466304), W. A. M., (14150130), S. M., (22963138), T. A., (832403), D. A., (14152548), R. B., . . . (284932), J. A. S. (2025). Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative.
Chicago Style (17th ed.) Citation(18295396), Rania Abdel-latif, et al. Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative. 2025.
MLA (9th ed.) Citation(18295396), Rania Abdel-latif, et al. Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative. 2025.
Warning: These citations may not always be 100% accurate.